Islet cells in human type 1 diabetes: from recent advances to novel therapies ? a symposium-based roadmap for future research

Cantley, J., Eizirik, D.L., Latres, E. and Dayan, C.M. ORCID: https://orcid.org/0000-0002-6557-3462 2023. Islet cells in human type 1 diabetes: from recent advances to novel therapies ? a symposium-based roadmap for future research. Journal of Endocrinology 259 (1) , e230082. 10.1530/JOE-23-0082

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (5MB) | Preview

Abstract

There is a growing understanding that the early phases of type 1 diabetes (T1D) are characterised by a deleterious dialogue between the pancreatic beta cells and the immune system. This, combined with the urgent need to better translate this growing knowledge into novel therapies, provided the background for the JDRF–DiabetesUK–INNODIA–nPOD symposium entitled ‘Islet cells in human T1D: from recent advances to novel therapies’, which took place in Stockholm, Sweden, in September 2022. We provide in this article an overview of the main themes addressed in the symposium, pointing to both promising conclusions and key unmet needs that remain to be addressed in order to achieve better approaches to prevent or reverse T1D.

Item Type:	Article
Date Type:	Published Online
Status:	Published
Schools:	Medicine
Publisher:	BioScientifica
ISSN:	0022-0795
Date of First Compliant Deposit:	5 October 2023
Date of Acceptance:	13 August 2023
Last Modified:	07 Oct 2023 18:37
URI:	https://orca.cardiff.ac.uk/id/eprint/162986

Citation Data

Cited 2 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item